Genprex, Inc. Current Assets
Genprex, Inc. (GNPX) had Current Assets of $15.84 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $15.84M.
- 2026-03-31: Assets, Current $18.80M.
- 2025-12-31: Assets, Current $8.36M; Assets, Current as first filed $8.36M.
- 2025-09-30: Assets, Current $1.72M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $15.84M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $18.80M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $8.36M 10-Q · filed 2026-08-14 | $8.36M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.72M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.06M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.16M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.08M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.92M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.39M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $9.23M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $7.53M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $12.86M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $12.37M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $19.94M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $21.47M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $26.31M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $30.90M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $35.70M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $39.14M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $45.64M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $48.06M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $50.38M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $27.70M 10-K · filed 2022-03-30 | $30.72M 10-K · filed 2021-03-26 |
| 2020-09-30 | $22.71M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $24.16M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $24.03M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $2.98M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.61M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $5.80M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $7.05M 10-Q/A · filed 2019-05-20 | |
| 2018-12-31 | $8.85M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $10.69M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $12.54M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $58.40K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $193.57K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $400.76K 10-Q · filed 2017-12-05 | |
| 2016-12-31 | $1.64M 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |